LAURUS LABS

KEENLY FOCUSED ON GROWTH

Laurus Labs has showcased impressive growth in the custom synthesis and FDF segments, capitalising on the rising demand for CDMO services. Geopolitical developments, such as the U.S. Biosecure Act aimed at reducing dependence on Chinese pharmaceutical suppliers, have positioned Indian CDMO players, including Laurus Labs, to capture new opportunities. For long-term investors, the company holds potential